Pyrogens refer to those substances which cause fever after administration of injection. Rise in the temperature of human body as well as body ache are some of the major reactions caused owing to the injection of harmful pyrogens in the body. Pyrogen testing helps in determination of the presence of endotoxin substances present in the human body. The pyrogen testing market can be segmented on the basis of application, test type, end-user and regions. The rising support especially from governments of various economies in order to launch new and more innovative drug options to fight with several new types of diseases has bolstered the overall demand for pyrogen testing products in the recent past. In addition to this, pyrogens are widely known as a major cause to body ache and fever after being injected into the human body. This testing of pyrogens helps in easy identification of the presence of endotoxin substances and is being widely used especially in the development of improved and new drugs across the globe.
Increasing growth of global pyrogen testing market is primarily anticipated to be the result of increasing number of biotechnology and pharmaceutical companies across the globe. In addition, increasing investments in research and development activities as well as rising approvals for new and improved drugs is another major factor bolstering the growth of pyrogen testing market, globally. Also, other factors such as increasing prevalence of chronic diseases, rising healthcare expenditure and favorable government support programs and initiatives are further augmenting the growth of global pyrogen testing market over the forecast period. However, factors such as high barrier for new market entrants is one of the key aspects anticipated to hamper the growth of pyrogen testing market over the forecast period. On the other hand, increasing medical tourism, especially in developing regions such as Latin America and Asia-Pacific, coupled with a rapidly growing healthcare industry in emerging economies such as India, China, Japan, Indonesia, Argentina, and Brazil among others are considered to be the future landscape for global pyrogen testing market over the forecast period. Moreover, increasing discovery of new and more innovative drugs along with huge investments in overall sunk costs, especially by biotechnological and pharmaceutical companies, coupled with rising support by the governments of various economies across the globe in healthcare sector are some other elements fueling the growth of pyrogen testing market.
The global pyrogen testing market can be segmented on the basis of application, product type and geography. On the basis of application, the global pyrogen testing market can be segmented into pharmaceuticals and biotechnology, medical devices manufacturing and others. By product type, the global pyrogen testing market can be segmented into kits & reagents, services and instruments. On the basis of region, the global pyrogen testing market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific. The demand in Asia-Pacific is analyzed to be the major driving factor for the growth of the pyrogen testing market. China is analyzed to lead the demand for pyrogen testing due to increased industrial production in the past half decade. The markets in emerging economies such as Brazil and India are also projected to grow rapidly.
Key players involved in the global pyrogen testing market are focusing on key market strategies such as acquisitions and mergers with local as well as established players. Moreover, companies are also focusing on collaborating with local players to increase their reach across all geographies and earn huge profits. Partnership with multinational companies to strengthen their market reach and goodwill is also anticipated to be a major market strategy in the global pyrogen testing market. Some of the major players involved in the manufacture and supply of pyrogen testing include Hyglos GmbH, Associates of Cape Cod Inc, GenScript, Wako Chemicals USA Inc., Charles River Laboratories International Inc.,Ellab A/S, Merck & Co Inc., Lonza Group, Sigma-Aldrich Corporation, and Thermo Fisher Scientific Inc.
Market by Product
· Kits & reagents
Market by Application
· Pharmaceuticals and biotechnology
· Medical devices manufacturing
Market by Geography
· North America
o Rest of Europe
o Rest of Asia-Pacific
· Latin America
o Rest of Latin America
· Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o Rest of MEA
Healthcare drones provide medical care facilities for the people in a few minutes to bring blood, medicines, serum snake bite, birth control, and other resources to rural areas, which in some situations could be the difference between life and death. Market Insights Increased awareness of healthcare drones is likely to fuel dema
The Global Metal Implants and Medical Alloys Market size is expected to garner around US$ 19.5 Bn by 2026, growing at a CAGR of around 9.2% over the forecast period 2019 to 2026. Metal implants are the biomaterials that are used to place inside or on the surface of the body. These are basically made up of stainless steel, Cobalt Chrome (CoCr) alloys, Titanium (Ti), and Ti alloys are widely used in orthopedic i
The Global Next Generation Sequencing Market is expected to grow at a CAGR of around 18.7% over the forecast period 2019 to 2026 and poised to reach around US$ 20.4 Bn by 2026. Next Generation Sequencing (NGS) is a platform that enabled the sequencing of thousands to millions DNA molecules simultaneously. It is also known as the massively parallel sequencing technology. This sequencing helps in the various fie
The global ultrasound equipment market is expected to grow at a CAGR of around 6.3% from 2019 to 2026 and expected to reach the market value of around US$ 10 Bn by 2026. Ultrasound is a medical imaging technology that uses sound waves to produce pictures of body’s inside part. It helps to diagnose swelling, pain, and infection in internal organs and to examine a baby in pregnant women. Ultrasound is also
The global minimally invasive surgery market is expected to grow at a CAGR of around 9.6% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 33.8 Bn by 2026. Minimally invasive surgery uses techniques to operate with less incision or damage to the body than open surgery. Hence, it is associated with less pain, fewer postoperative complications, and short
The global implantable medical devices market is expected to grow at a CAGR of around 7.3% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 153.8 Bn by 2026. An implant is a medical device, manufactured to support or replace any damaged organs in the body, treat imperfections in normal body functions, or enhance the functioning of body organs. These can be implanted by